Kuala lumpur: KL Wellness City (KLWC) and KL International Hospital (KLIH) have signed a strategic healthcare cooperation agreement with China's Boao LeCheng International Medical Tourism Pilot Zone, located in the Hainan Free Trade Port, marking a significant step towards transforming the regional medical tourism and healthcare innovation landscape.
According to BERNAMA News Agency, KL Wellness City Sdn Bhd stated that the agreement marks the first-ever partnership between Boao LeCheng and a Malaysian hospital, establishing a significant bridge between two leading medical tourism and wellness destinations in Asia. KLWC managing director Datuk Dr Colin Lee emphasized the shared commitment of both parties to improving health outcomes, driving medical innovation, and benefiting patients in the two countries.
The agreement, which is expected to reshape the regional medical tourism and healthcare innovation landscape, was signed recently by Dr Lee and KLIH executive director Datuk Dr Jacob Thomas, together with deputy director of the LeCheng Administration, Yi Tuoxin. KLWC executive director Datuk Seri Dr Vincent Tiew described the collaboration as a significant milestone encompassing joint initiatives in medical tourism, clinical research, cutting-edge technology exchange, and specialist training.
According to the statement, KLWC is Southeast Asia's first fully integrated 26.5-acre township in Bukit Jalil dedicated to health and wellness, where medical, residential, commercial, and leisure components are purpose-built to foster a holistic and sustainable lifestyle. KLIH, equipped with smart hospital infrastructure and advanced medical technologies, is slated to open in the second half of 2026, offering a comprehensive range of specialist and sub-specialist services for both local and international patients.
LeCheng Administration director Fu Sheng highlighted that KLWC and KLIH bring valuable expertise in healthcare operations and international medical services to the partnership. Boao LeCheng is internationally recognized for its access to advanced medical technologies, expedited approval pathways for novel treatments, and as a model zone for global healthcare innovation. It is positioned as a hub for international medical innovation, equipped with world-class healthcare facilities and fast-track access to cutting-edge treatments and pharmaceuticals not yet available elsewhere in China.